Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 10.03
-0.30 (-2.90%)
Sep 11, 2026, 3:04 PM CST
SHE:000403 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 812.18 | 770.16 | 1,321 | 1,429 | 1,001 | 885.67 |
Trading Asset Securities | 259.8 | 254.39 | 282.7 | 423.34 | 422.44 | 234.21 |
Cash & Short-Term Investments | 1,072 | 1,025 | 1,604 | 1,853 | 1,423 | 1,120 |
Cash Growth | 3.45% | -36.12% | -13.43% | 30.18% | 27.09% | 989.09% |
Accounts Receivable | 859.22 | 1,089 | 710.69 | 592.77 | 891.08 | 581.12 |
Other Receivables | 12.14 | 9.17 | 6.5 | 42.34 | 49.71 | 12.83 |
Receivables | 871.36 | 1,098 | 717.19 | 635.11 | 940.79 | 593.95 |
Inventory | 1,918 | 1,578 | 1,245 | 924.06 | 623.69 | 738.97 |
Prepaid Expenses | 23.52 | 18.93 | 11.37 | 12.35 | 0.14 | 0 |
Other Current Assets | 29.75 | 1.24 | 1.61 | 1.87 | 59.12 | 16.53 |
Total Current Assets | 3,915 | 3,721 | 3,579 | 3,426 | 3,047 | 2,469 |
Property, Plant & Equipment | 2,030 | 2,072 | 1,999 | 1,554 | 1,297 | 1,103 |
Long-Term Investments | - | - | 6 | - | - | - |
Goodwill | 2,536 | 2,536 | 2,615 | 2,615 | 2,615 | 2,615 |
Other Intangible Assets | 181.48 | 190.22 | 200.33 | 212.59 | 192.52 | 200.05 |
Long-Term Deferred Tax Assets | 24.99 | 26.58 | 29.43 | 49.04 | 49.09 | 27.35 |
Long-Term Deferred Charges | 255.63 | 229.9 | 153.55 | 79.47 | 89.7 | 67.42 |
Other Long-Term Assets | 842.35 | 690.46 | 664.24 | 694.87 | 692.81 | 605.82 |
Total Assets | 9,785 | 9,466 | 9,246 | 8,630 | 7,982 | 7,088 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 206.18 | 155.26 | 224.26 | 154.35 | 158.37 | 158.7 |
Accrued Expenses | 225.15 | 311.19 | 335.48 | 372.84 | 373.49 | 239.21 |
Short-Term Debt | 741.39 | 535.7 | 310.49 | 250.57 | 275.1 | 113.52 |
Current Portion of Long-Term Debt | 66.04 | 59.84 | 17.06 | 21.22 | 8.63 | - |
Current Portion of Leases | 3.79 | 2.75 | 5.06 | 6.67 | 7.14 | 7.05 |
Current Income Taxes Payable | 4.56 | 15.58 | 19.07 | 39.72 | 43.08 | 24.22 |
Current Unearned Revenue | 3.9 | 3.04 | 6.36 | 10.76 | 25.91 | 11.54 |
Other Current Liabilities | 35.5 | 45.12 | 39.2 | 66.06 | 67.58 | 88.04 |
Total Current Liabilities | 1,287 | 1,128 | 956.97 | 922.19 | 959.31 | 642.29 |
Long-Term Debt | 375.99 | 193.83 | 303.22 | 196.08 | 52.89 | - |
Long-Term Leases | 13.56 | 11.94 | 18.6 | 21.48 | 29.59 | 20.89 |
Long-Term Unearned Revenue | 46.99 | 36.97 | 26.84 | 35.6 | 40.08 | 49.24 |
Long-Term Deferred Tax Liabilities | 11.49 | 13.87 | 14.13 | 24.26 | 30.33 | 36.52 |
Other Long-Term Liabilities | - | - | 9 | 9 | 9 | 11.14 |
Total Liabilities | 1,735 | 1,385 | 1,329 | 1,209 | 1,121 | 760.07 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 950.4 | 950.4 | 731.07 | 733 | 732.39 | 732.92 |
Additional Paid-In Capital | 4,539 | 4,539 | 4,758 | - | 4,779 | 4,779 |
Retained Earnings | 2,683 | 2,599 | 2,435 | 1,946 | 1,392 | 846.23 |
Treasury Stock | -116.06 | - | - | -43.17 | -36.22 | -32 |
Comprehensive Income & Other | 0.02 | 0.04 | 0.05 | 4,793 | 0.04 | -0 |
Total Common Equity | 8,056 | 8,088 | 7,925 | 7,429 | 6,868 | 6,326 |
Minority Interest | -6.11 | -6.78 | -7.15 | -6.79 | -6.4 | 2.07 |
Shareholders' Equity | 8,050 | 8,081 | 7,918 | 7,422 | 6,861 | 6,328 |
Total Liabilities & Equity | 9,785 | 9,466 | 9,246 | 8,630 | 7,982 | 7,088 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,201 | 804.06 | 654.44 | 496.02 | 373.36 | 141.46 |
Net Cash (Debt) | -128.79 | 220.48 | 949.39 | 1,357 | 1,050 | 978.42 |
Net Cash Growth | - | -76.78% | -30.02% | 29.22% | 7.30% | - |
Net Cash Per Share | -0.14 | 0.23 | 0.99 | 1.43 | 1.10 | 1.06 |
Filing Date Shares Outstanding | 937.97 | 950.4 | 950.4 | 950.06 | 952.1 | 952.8 |
Total Common Shares Outstanding | 937.97 | 950.4 | 950.4 | 950.34 | 952.1 | 952.8 |
Working Capital | 2,628 | 2,593 | 2,622 | 2,504 | 2,088 | 1,827 |
Book Value Per Share | 8.59 | 8.51 | 8.34 | 7.82 | 7.21 | 6.64 |
Tangible Book Value | 5,339 | 5,362 | 5,110 | 4,601 | 4,060 | 3,511 |
Tangible Book Value Per Share | 5.69 | 5.64 | 5.38 | 4.84 | 4.26 | 3.68 |
Buildings | 1,265 | 1,266 | 1,180 | 833.6 | 701.14 | 583.25 |
Machinery | 1,566 | 1,563 | 1,184 | 961.1 | 920.37 | 729.45 |
Construction In Progress | 246.43 | 225.99 | 513.36 | 582.7 | 385.73 | 334.38 |